Cancer screening in the postmenopausal woman

Clinical Obstetrics and Gynecology

Volumn 39, Issue 4, 1996, Pages 889-892

  Seltzer, Vicki ^a,b  

^a LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; BARIUM; CA 125 ANTIGEN; TAMOXIFEN;

BIOPSY; BREAST CANCER; BREAST EXAMINATION; CANCER MORTALITY; CANCER SCREENING; CANCER SURVIVAL; CIGARETTE SMOKING; COLORECTAL CANCER; ECHOGRAPHY; ENDOMETRIUM CANCER; ENDOSCOPY; FEMALE; HUMAN; LEUKEMIA; LUNG CANCER; LYMPHOMA; MAMMOGRAPHY; MOUTH CANCER; OVARY CANCER; PAPANICOLAOU TEST; POSTMENOPAUSE; REVIEW; SKIN CANCER; UTERINE CERVIX CANCER; VAGINA CANCER; VULVA CANCER;

AGE DISTRIBUTION; AGED; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; INCIDENCE; MASS SCREENING; MIDDLE AGED; NEOPLASMS; POSTMENOPAUSE; UNITED STATES;

EID: 0029806719     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003081-199612000-00017     Document Type: Review

References (5)

1. Pearse WH. Smoking cessation. Prim Care Update Ob/Gyns 1994;1:9.
2. Fisher B, Costantino JP, Redmond CK, et al. Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project. J Natl Cancer Inst. 1994;86:527.
3. Speroff L. Tamoxifen: important gynecologic considerations. Menopausal Med. 1995;3:5.
4. NIH Consensus Development Panel on Ovarian Cancer. Ovarian cancer - screening, treatment, and follow-up. JAMA. 1995;273:491.
5. Lazarchik DA, Filler SJ. Oral screening exam for the primary care physician. Prim Care Update Ob/Gyns 1996;3:108-113.